-
AMAM Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Ambrx Biopharma (AMAM)
Company Profile
Quarter (USD) | Jun 23 | Mar 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 228.93 mm | 228.93 mm | 228.93 mm | 228.93 mm | 228.93 mm | 228.93 mm |
Cash burn (monthly) | (no burn) | (no burn) | 6.39 mm | 2.93 mm | 224.33 k | 1.14 mm |
Cash used (since last report) | n/a | n/a | 113.85 mm | 52.27 mm | 4.00 mm | 20.25 mm |
Cash remaining | n/a | n/a | 115.08 mm | 176.66 mm | 224.93 mm | 208.68 mm |
Runway (months of cash) | n/a | n/a | 18.0 | 60.2 | 1002.7 | 183.6 |
13F holders | Current |
---|---|
Total holders | 51 |
Opened positions | 19 |
Closed positions | 5 |
Increased positions | 12 |
Reduced positions | 8 |
13F shares | Current |
---|---|
Total value | 754.91 bn |
Total shares | 188.40 mm |
Total puts | 243.90 k |
Total calls | 342.60 k |
Total put/call ratio | 0.7 |
Largest owners | Shares | Value |
---|---|---|
HOPU Reunion | 38.95 mm | $351.74 mm |
WuXi PharmTech Healthcare Fund I | 29.27 mm | $264.29 mm |
Venrock Healthcare Capital Partners III | 26.74 mm | $74.34 mm |
D. E. Shaw & Co | 22.05 mm | $276.51 mm |
Darwin Global Management | 16.69 mm | $274.69 bn |
Artal International S.C.A. | 15.07 mm | $0.00 |
Cormorant Asset Management | 9.62 mm | $158.28 bn |
HBM Healthcare Investments | 8.40 mm | $0.00 |
D. E. Shaw & Co. | 4.02 mm | $66.10 bn |
Commodore Capital | 3.18 mm | $52.26 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 Sep 23 | Cormorant Asset Management | Ordinary Shares | Buy | Acquire P | Yes | No | 9.2447 | 751,233 | 6.94 mm | 69,465,823 |
15 Sep 23 | Cormorant Asset Management | Ordinary Shares | Buy | Acquire P | Yes | No | 9.0479 | 1,401,505 | 12.68 mm | 68,714,590 |
1 Sep 23 | Dalesandro Margaret | Ordinary Shares | Grant | Acquire A | No | No | 0 | 70,833 | 0.00 | 70,833 |
1 Sep 23 | Dalesandro Margaret | Ordinary Shares | Grant | Acquire A | No | No | 0 | 125,000 | 0.00 | 125,000 |
27 Jun 23 | Darwin Global Management | American Depository Shares ("ADSs") Ordinary Shares | Buy | Acquire P | Yes | No | 13.93 | 5,384,063 | 75.00 mm | 16,688,636 |